Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3437]
News [7969]
Articles [64]
Editorials [9]
Conferences [213]
elearning [49]
ESMO 2012: New findings on optimal duration of trastuzumab therapy for women with HER2-positive early breast cancer
ESMO 2012: New findings on optimal duration of trastuzumab therapy for women with HER2-positive early breast cancer
Synergy of kinase inhibitors in imatinib-resistant CML
Synergy of kinase inhibitors in imatinib-resistant CML
Bortezomib licensed for subcutaneous administration
Bortezomib licensed for subcutaneous administration
ESMO 2012: New weapons in the fight against cancer
ESMO 2012: New weapons in the fight against cancer
ESMO 2012: Are too few women being offered breast-conserving treatment?
ESMO 2012: Are too few women being offered breast-conserving treatment?
ESMO 2012: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial
ESMO 2012: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III...
ESMO 2012: Studies show advances in gastrointestinal cancer treatments
ESMO 2012: Studies show advances in gastrointestinal cancer treatments
ESMO 2012: Multiple studies show drug combinations effective for melanoma
ESMO 2012: Multiple studies show drug combinations effective for melanoma
New trial will investigate cancer-fighting properties of chemical related to cannabis
New trial will investigate cancer-fighting properties of chemical related to cannabis
Predicting erectile dysfunction from prostate cancer treatment
Predicting erectile dysfunction from prostate cancer treatment

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation